Deprescribing is not just the responsibility of pharmacists, co-chairs for the English Deprescribing Network (EDeN) have stressed.
The cost of medicines prescribed by hospitals and in primary care has increased by 4% to of £18.9bn in 2018/2019.
Pharmacy leads responsible for an area that covers 1.5 million people have warned that “urgent action” to increase pharmacy training funds is needed if the pharmacy workforce is to deliver on the ‘NHS long-term plan’.
GPs are set to vote on whether pharmacists should be “responsible for identifying appropriate and available alternatives” when medicines are in short supply.
Rapid tests for group A streptococcal infections have not been recommended for routine adoption for people with a sore throat.
The hepatitis A and B vaccine has been added to the list of medicines that cannot be parallel exported from the UK.
Using an oral spray to deliver vitamin D is just as effective as a capsule, research published in the European Journal of Clinical Nutrition has shown.
Decision aids could help GPs and patients in the process of discontinuing antidepressants, researchers have said.
Oral antibiotic use is linked to an increased risk of colon cancer, but a reduced risk of rectal cancer, a study in Gut suggests.
Patients exposed to fluoroquinolone antibiotics are more than twice as likely to develop aortic or mitral regurgitation, compared with patients taking amoxicillin, according to research published in the Journal of the American College of Cardiology.
Patients treated with nivolumab for advanced non-small cell lung carcinoma had a better survival rate at five years than those who received chemotherapy, a follow-up trial has shown.
Sertraline is unlikely to reduce depressive symptoms within six weeks, according to findings from a randomised controlled trial in The Lancet Psychiatry.